Anjulika Chawla, MD, FAAP
bluebird bio, Inc.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Anjulika Chawla, MD, FAAP as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:52 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT04293185 · A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell DiseaseGenetix Biotherapeutics Inc. · active not recruiting · Sickle Cell Disease · study director
- Ph1/Ph2NCT02140554 · A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell DiseaseGenetix Biotherapeutics Inc. · completed · Sickle Cell Disease · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.